Contact the Editorial Desk

Editorial correspondence

Peptide Ways welcomes correspondence on the research record: a citation quoted inaccurately, a regulatory reference gone out of date, or a peer-reviewed study on DSIP or Selank that should be added to the references page. Corrections that improve the accuracy of the digest are the most useful messages we receive and are read carefully.

The most actionable notes specify three things: the page they refer to, the exact passage in question, and the supporting citation — a DOI or PubMed ID wherever possible. That lets us verify a proposed change against the source directly.

Editorial mailbox: editors@peptideways.com

What this desk cannot do

So no message goes unanswered for the wrong reason, several requests sit outside what this site can handle. Peptide Ways charts the literature; it neither practices medicine nor sells anything, so it cannot:

• Advise on, recommend, or comment on human use of DSIP, Selank, or any other peptide.
• Put a dose, schedule, or route on any individual's plan.
• Diagnose a condition or judge whether a particular finding fits a particular person.
• Sell, source, recommend, or help locate any compound from any supplier.
• Answer athletes subject to anti-doping rules about using these compounds — both sit under WADA's S0 non-approved-substances catch-all.

Readers seeking guidance on sleep or anxiety should consult a licensed clinician in their own jurisdiction. Replies to editorial correspondence are not guaranteed and may be delayed; the mailbox is monitored intermittently.